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The MYC–MAX–MXD network is involved in the regulation of cell differentiation and proliferation.
Hypoxia affects the expression levels of several members of this network, but changes speciﬁc to
MAX expression have so far not been shown. We found that in endothelial cells, hypoxia induces
alternative splicing ofMAX, thereby increasing the expression of twoMAX isoforms that differ from
the wild type in their 30 end. Isoform C is degraded by nonsense-mediated decay and isoform E
encodes a highly unstable protein. The instability of isoform E is conferred by 36 isoform-speciﬁc
amino acids, which have the capacity to destabilize heterologous proteins. Both splicing events
are therefore unproductive and serve the purpose to downregulate the wild type protein.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MAX (MYC associated factor X) is a ubiquitously expressed
transcription factor and the central part in a network of several
transcriptional regulators involved in apoptosis, cell differentia-
tion, proliferation and transformation. MAX forms heterodimers
with MYC oncoproteins (c-MYC, L-MYC, N-MYC) stimulating cell
proliferation as well as several MYC antagonists (MXD1–4, MNT,
MGA), which inhibit proliferation and contribute to differentiation
[1]. In addition, MAX can form homodimers, but it is unclear if
homodimerization impacts on its function in vivo [2]. All network
members encode a basic Helix-Loop-Helix Leucine Zipper domain
(bHLHLZ) for DNA-binding and dimerization. The different MAX
complexes compete for the same DNA motif (E-box) in the pro-
moter region of a vast number of target genes. Usually MAX/MYC
complexes activate gene expression by histone modiﬁcation and
increased transcription elongation, whereas MAX/MXD complexes
repress gene expression. MYC expression is deregulated in various
types of cancer and its tumorigenic potential seems to depend on
the expression of other network members [1]. MAX mutations
are associated with pheochromocytoma and small-cell lung cancer
[3,4].MYC proteins are short lived (15–20 min), their levels heav-
ily regulated on the transcriptional and posttranscriptional level
[5]. In contrast, MAX wild type (WT) protein is very stable
(>24 h) and abundantly expressed, with only few examples of
posttranscriptional gene regulation [6]. Two miRNAs (miR-22
and miR-193b) have been shown to downregulate MAX expres-
sion and thereby inhibit cell cycle progression in normal and
cancer cells [7–9]. Further, alternative splicing of exon 2 gives
rise to a long (p22) and a short (p21) protein differing by a nine
amino acid (aa) insertion at the N-terminus and the tendency to
homodimerize [10]. In addition, mRNA isoforms encoding
C-terminal truncated MAX variants have been reported [11,12].
These are created either by retention of intron 4 (isoform E) or
by inclusion of a cassette exon located within intron 4 (isoform
C) (Fig. 1A). Both C-terminal isoforms have been shown to
enhance the transforming activity of c-MYC in vivo, whereas
WT MAX reduces it.
To increase chances of survival under prolonged hypoxic condi-
tions, cells decrease their energy consumption, amongst other
measures, by decreasing their proliferation rate. MYC protein is
downregulated by decreased translation efﬁciency and destabiliza-
tion of the protein [13]. In addition, its function is counteracted by
displacement of MAX/MYC complexes from promoter binding sites
and upregulation of its antagonist MXD2 (also MXI1) [14]. Until
now, no regulation of MAX has been reported under hypoxia.
Recently, we discovered that the mRNA of isoform E is upregulated
Fig. 1. C-terminal MAX mRNA isoforms are upregulated during hypoxia and partially targeted to NMD. (A) MAX mRNA isoforms coding for proteins with different C-termini.
In isoform C a cassette exon (blue) located within intron 4 is retained. Due to alternatively used 50 splice sites, the cassette exon exists in two different lengths (indicated in
light and dark blue). Retention of the complete intron 4 (orange) leads to isoform E expression. Arrows show the location of primer pairs used for the qRT-PCRs in Fig. 1B and
C. (B) MAX mRNA isoforms C and E are induced during hypoxia. (left) qRT-PCR quantiﬁcation of isoforms C and E isolated from normoxic and hypoxic HUVECs. Two primer
pairs binding within intron 4 up- and downstream of the cassette exon were used for the quantiﬁcation of isoform E, to ensure complete intron retention. Isoforms are
normalized to the total MAX mRNA amount. n = 3, ⁄⁄P-value <0.01. (right) RT-PCRs of isoforms C and E. For detection of isoform C (C1 and C2), eight additional ampliﬁcation
rounds compared to isoform E (E1 and E2) were used, to generate a visible signal. The housekeeping gene RPLP0 (P0) is shown as loading control. N = normoxia, H = hypoxia.
(C) Isoform C is a NMD target in HUVECs. (left) RT-PCR from isoform C and E after CHX treatment in normoxic and hypoxic HUVECs. RPLP0 (P0) is shown as loading control.
(center) qRT-PCR quantiﬁcation of UPF1 mRNA after siRNA-mediated knockdown in HUVECs. (right) qRT-PCR quantiﬁcation of isoforms C and E after UPF1 knockdown in
HUVECs. Expression values are normalized to RPLP0. n = 3, ⁄⁄P-value <0.01, n.s. = not signiﬁcant.
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that during hypoxia both mRNAs encoding C-terminal truncated
MAX variants are upregulated, whereas the WT is reduced on
mRNA and protein level. Upregulation of these mRNAs, however,
does not lead to a detectable production of the corresponding pro-
tein isoforms. Isoform C is targeted to the nonsense-mediated
decay (NMD) pathway. Isoform E encodes a highly unstable pro-
tein, with the last 36 aa inducing an extremely efﬁcient downreg-
ulation also when attached to heterologous proteins. Therefore, the
sole purpose of this intricate splicing regulation seems to be the
reduction of WT protein levels. As MAX is part of all MYC and
MXD heterodimers, its reduction impacts on the activity of the
whole network.2. Materials and methods
2.1. Cell culture and transfection
2.1.1. Endothelial cells
Pooled HUVECs (Lonza) were grown in endothelial cell basal
medium (EBM), supplemented with EGM SingleQuots (except
ascorbic acid) (both Lonza) and 10% FCS (Gibco) in T75 ﬂasks
(Greiner) and used from the second or third passage. For plasmid
transfection HUVECs were grown in T75 ﬂasks to 60–70%
conﬂuence, detached with trypsin–EDTA (Gibco) and neutralized
with trypsin neutralization solution (Lonza). 1  106 cells were
transfected using the 4D-Nucleofector™ and P5 primary cell
4786 K. Kemmerer, J.E. Weigand / FEBS Letters 588 (2014) 4784–4790solution (both Lonza) according to the manufacturer’s protocol.
Cells were either transfected with 2 lg of pFLAG or with 5 lg pEGFP
constructs, respectively. After electroporation, cells were split in
two wells of a 12-well plate (Greiner). Cells were supplied with
fresh medium after 24 and 48 h and then incubated for additional
48 h at normoxia or hypoxia (1% O2 in a New Brunswick CO2/O2
incubator). For siRNA-mediated gene silencing, 1.5  106 cells were
seeded into 6 cm dishes (Greiner) and transfected after 18–24 h
using RNAiMAX reagent (Invitrogen). UPF1 siRNA (GCAUGUAC
UUCCAGACCCA) or scrambled siRNA (UUCUCCGAACGUGUCACGU)
as a control were transfected at a ﬁnal concentration of 5 nM and
incubated for 48 h. For CHX treatment 1.5  106 cells were seeded
into 6 cm dishes. 18–24 h after seeding, cells were supplied with
fresh medium and incubated for additional 48 h at normoxia or
hypoxia. CHX (Roth) was added to a ﬁnal concentration of 5 or
10 lM and cells were cultured for additional 8 h.
2.1.2. HeLa cells
HeLa cells (DSMZ) were cultured in T75 ﬂasks in Dulbecco’s
modiﬁed Eagle’s medium (Sigma) supplemented with 10% FCS
(Biochrom), 1 mM sodium pyruvate (Gibco) and Pen Strep (Gibco).
For transfection, cells were seeded to a conﬂuence of 80–90%. 24 h
after seeding, cells were transfected using Lipofectamine2000
(Invitrogen). For Western Blot analysis cells were transfected with
375–1500 ng of pFLAG or pEGFP constructs. Samples were pre-
pared 24 h post transfection. For CHX treatment HeLa cells were
transfected with pEGFP/P constructs, CHX was added 18 h after
transfection to a ﬁnal concentration of 10 lg/ml, protein was pre-
pared at the indicated time points. For MG132, chloroquine or pro-
tease inhibitor (all Sigma) treatment HeLa cells were transfected
with pFLAG constructs. 18 h after transfection MG132 was added
to a ﬁnal concentration of 10 lM, concentration of protease inhib-
itors was as indicated. Cells were cultured for 24 h prior to protein
preparation. For dual luciferase assays, HeLa cells were transfected
in triplicates, each well with 100 ng pDL constructs and luciferase
activity was measured 24 h after transfection using the Dual-Glo
system (Promega). For each well the ﬁreﬂy values were normalized
to the Renilla values of the same well. For localization studies,
2  105 HeLa cells were seeded in a 6-well plate containing glass
cover slips and cultured for 24 h. Cells were transfected with pEG-
FP and were ﬁxed with 3% formaldehyde in phosphate-buffered
saline after 24 h. The nucleus was stained with 1 lg/ml Hoechst
33258 (Sigma).
Plasmid constructions are given in the Additional methods
section.
2.2. RNA isolation
Total RNA from HUVECs was isolated using the miRNeasy Mini
kit, including the optional on-column DNA digestion with the
RNase-Free DNase Set (both Qiagen). Total RNA from HeLa cells
was isolated using TRIzol (Invitrogen), followed by TURBO DNase
(Ambion) treatment. After isolation 1 lg RNA was quality checked
on a 1% agarose gel.
2.3. RT- and qRT-PCR
RT-PCR analysis and qRT-PCR quantiﬁcation was performed as
in [15]. Primers are listed in Table S1.
2.4. Western Blot
For Western Blot analyses, cells were lysed in lysis buffer
[137 mM NaCl, 10% glycerol, 20 mM Tris–HCl pH 8.0, 2 mM EDTA
pH 8.0, 1% Igepal, 5 ll protease inhibitor cocktail (Sigma)] for
20 min on ice. After centrifugation (15 min at 17000g, 4 C) theprotein content of the samples was determined in triplicates
according to the Bradford method. 10–20 lg protein were loaded
onto precast gels and blotted onto PVDF membranes (both
Bio-Rad). Primary antibodies targeting the FLAG-epitop (Sigma
A-8592), GFP (Roche 11814460001), HA-epitop (Roche 12CA5),
MAX (Santa Cruz sc-197) or b-Actin (Sigma A-5441) were used.
Horseradish peroxidase-conjugated anti-mouse or rabbit IgG (Jack-
son Immunoresearch) were used as secondary antibodies. Blots
were developed with the ECL system (Bio-Rad) or ECL select (Life
technologies) for weaker signals. Images were detected using the
ChemiDoc Imaging System (Bio-Rad) and quantiﬁed using Image
Lab Software (Bio-Rad).
2.5. In vitro translation
RNA was produced in an in vitro transcription reaction for 3 h at
37 C using the following conditions: linearized DNA (20 ng/ll of
pIVTL-constructs), 40 mM Tris–HCl pH 8.0, 10 mM NaCl, 6 mM
MgCl2, 2 mM spermidine, 10 mM DTT, 0.16 U/ll RNasin (Promega),
0.5 mM NTP mix, T7 Polymerase (self made) and followed by
DNase I (NEB) digestion using 0.02 U/ll DNase I for 15 min at
37 C. In vitro transcribed RNA was puriﬁed using phenol chloro-
form extraction and ethanol precipitation. In vitro translation with
wheat germ extract (Promega) was performed according to the
manufacturer’s protocol using 0.1 lg/ll transcribed RNA.
2.6. Statistical analysis
Statistical analysis was done using student’s t-test. All bar
graphs are given as mean values ± standard deviation.
3. Results and discussion
3.1. Hypoxia-induced MAX mRNA isoforms are partially targeted to
NMD
We identiﬁed two MAX mRNA isoforms (C and E) that are
upregulated during hypoxia in human umbilical vein endothelial
cells (HUVECs). Isoform E retains the complete intron 4, whereas
isoform C encodes an additional cassette exon with two different
lengths due to two alternatively used 50 splice sites (Fig. 1A, S1
and S2). mRNA amounts were quantiﬁed under normoxic and hyp-
oxic conditions. During hypoxia both variants of isoform C increase
6-fold and isoform E 3-fold (Fig. 1B). This increase is accompanied
by a corresponding decrease of WT mRNA and protein under
hypoxia (Fig. S3). As a result the level of the constitutive part of
the MAX mRNA stays constant (Fig. S3).
The cassette exon of isoform C encodes a stop codon upstream
of an exon-junction-complex. Therefore the mRNA is predicted to
be degraded by NMD. We tested whether the mRNA is subject to
NMD by cycloheximide (CHX) treatment and transient UPF1
knockdown (Fig. 1C). While isoform E expression is not affected
by either treatment, the amount of isoform C increases speciﬁcally.
Thus, isoform C is degraded via NMD in HUVECs. This is in contrast
to the ﬁnding in glioblastomas, where the C-terminally truncated
protein from isoform C is expressed and contributes to tumor
growth [16]. Expression in glioblastoma cells might be possible
as the NMD pathway is downregulated during brain development
[17]. If so, it seems that this MAX protein variant is expressed dur-
ing conditions in which NMD is compromised, where it carries out
distinct cellular functions.
3.2. Isoform E encodes a highly unstable protein
Isoform E codes for a 134 aa long protein that differs from the
WT sequence at its C-terminus (Fig. S1). To characterize isoform
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of the WT and isoform E. In addition, a third construct (FULL),
which additionally contains the sequence for intron 4 and there-
fore encodes all three possible mRNA isoforms (WT, C and E),
was constructed (Fig. 2A). Upon expression of the three constructs
in HeLa cells, we could not detect any protein derived from isoform
E, while the WT protein is readily detectable (Fig. 2B and C). We
quantiﬁed the mRNA levels derived from WT and E, to ensure that
absence of isoform E is not the result of reduced mRNA expression
(Fig. 2C). In addition, we analyzed the splicing pattern of the FULL
construct and found that it gives rise to all three mRNA isoforms
(Fig. 2B). Therefore, we would expect to detect expression of at
least two proteins (WT and E) from this construct. In contrast, pro-
tein from isoform E is readily detectable in an in vitro translation
assay (Fig. 2D). To exclude, that the protein expression in vivo is
inﬂuenced by the FLAG-tag or the preparation conditions of the
protein lysate, we tested the expression of isoform E with an N-ter-
minal HA-tag, with 5-fold more protease inhibitor cocktail in the
lysis buffer, with whole cells directly lysed in SDS-loading buffer
or within pelleted cell debris (Fig. S4A–C). We also analyzed if
the presence of the alternatively spliced exon 2 impacts on isoform
E expression (Fig. S4D). Further on, we tested whether isoform E isFig. 2. Isoform E codes for an unstable protein. (A) Scheme of FLAG constructs. All constr
encoding all three C-terminal isoforms. WT = wild type CDS, E = isoform E CDS. (B) The FU
the FULL construct expressed in HeLa cells. Anti-FLAG antibody was used to detect MAX
from the FLAG-FULL construct using FLAG-isoform speciﬁc primers. For isoform C (C), ﬁve
E (E) a negative control (RT) without cDNA was performed. (C) FLAG WT and E expressi
MAX fusion proteins and anti-Actin as loading control. (right) qRT-PCR quantiﬁcation of
RPLP0. (D) In vitro translation of FLAGWT and E. Western Blot using anti-FLAG antibody.
C-terminally fused to GFP. Anti-GFP was used to detect MAX fusion proteins, anti-Actin
code for an N-terminal FLAG-tag for detection. Numbers indicate the last aa. WT = full-len
regions of the protein are indicated. b = basic region, HLH = helix-loop-helix, LZ = leucine z
MAX WT. (G) Localization of GFP-MAX constructs (WT and E) in HeLa cells using the inexpressed under conditions, in which the mRNA expression is
increased. For that, we analyzed its expression in HUVECs under
hypoxia (Fig. S4E). None of the approaches led to detectable
amounts of protein. This is in accordance with the ﬁnding of
Västrik et al., who showed that the protein encoded by isoform E
has a very short half-life in rat embryo ﬁbroblasts [12]. Neverthe-
less it is able to enhance the transformation efﬁciency in a MYC-
RAS cotransformation assay in these cells. To ﬁnally detect protein
isoform E, we fused the CDS of isoform E to GFP, which is known to
stabilize proteins [18]. For GFP-E small protein amounts compared
to the GFP-WT fusion and an E-speciﬁc cleavage product were
observed (Fig. 2E). Conﬁrming the results of FLAG-E (Fig. S4E),
the expression of GFP-E is not signiﬁcantly increased during
hypoxia in HUVECs (Fig. S4F).
The WT and isoform E proteins share the ﬁrst 98 aa, which
encode the complete bHLH, but only part of the LZ domain. To
see, if the instability of isoform E is due to this incomplete LZ
domain or other WT speciﬁc C-terminal aa, we created several C-
terminal truncatedWT variants. These include a minimal construct
containing the shared aa (1–98), the WT with complete LZ domain
(1–103), one construct missing the basic region known to act as
nuclear localization sequence (NLS) (1–148) and one constructucts contain an N-terminal FLAG tag. FULL =MAX CDS containing intron 4, therefore
LL construct expresses all mRNA isoforms but only WT protein. (left) Western Blot of
fusion proteins and anti-Actin as loading control. (right) RT-PCR of mRNAs derived
additional ampliﬁcation rounds were used, to generate a visible signal. For isoform
on. (left) Western Blot of FLAG-MAX fusions. Anti-FLAG antibody was used to detect
FLAG-speciﬁc WT and isoform E mRNA levels. Expression values are normalized to
(E) Western Blot of GFP-MAX fusions. WT (GFP-WT) and isoform E (GFP-E) CDS were
as loading control. (F) Western Blot of MAX WT C-terminal truncations. All variants
gth MAX. Scheme of the different MAX WT domains is shown below. The structural
ipper, A = region of acidic aa, B = region of basic aa (NLS). Numbers indicate the aa of
dicated channels.
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(Fig. 2F). Truncated proteins are only detectable if at least the ﬁrst
134 aa are expressed, but levels are still decreased drastically when
compared to the WT (Fig. 2F). It seems that expression of an intact
bHLHLZ domain alone is not sufﬁcient for protein expression.
Addition of the (predicted) unstructured region 103–148 is essen-
tial to detect any protein, but the WT is only highly expressed as
full-length protein containing the NLS.
In contrast to the WT, isoform E is not predicted to encode a
NLS. Therefore, we ﬁrst visualized the localization of the GFP fusion
proteins. As expected, GFP-WT is located in the nucleus, while GFP-
E is localized in the cytoplasm (Fig. 2G). Next, we tested if the addi-
tion of a SV40-derived NLS stabilizes isoform E. As control we fused
the SV40 NLS to GFP (Fig. S5A) and to the ﬁrst 148 aa of the WT,
which are vastly stabilized upon addition of the basic region
encoding a NLS (compare Fig. 2F). In accordance, expression ofFig. 3. Different MAX C-termini are able to stabilize or destabilize heterologous protein
isoform E were fused C-terminally to the GFP/P or the luc2 gene. Numbers indicate the
Western Blot of different MAX C-termini fused to GFP/P (compare Fig. 3A). Numbers indic
used to detect MAX fusion proteins and anti-Actin as loading control. The same blot is
protein (de-)stabilization by luciferase assays. (left) The different MAX WT and isofor
expression was measured. Activity of Renilla luciferase was measured as transfection con
(luc2, black bars). Luc2/P = ﬁreﬂy luciferase containing the destabilization domain from
qRT-PCR quantiﬁcation of ﬁreﬂy luciferase mRNA amounts from the indicated C-terminal
n = 3, n.s. = not signiﬁcant. (D) Protein half-life determination of GFP/P with different
treatment. Numbers indicate the amino acids of the WT or isoform E (E) fused to the C-
Relative protein expression levels are mean values from two experiments, normalized tthe truncated WT increases upon addition of the SV40 NLS. Also
for isoform E a faint band is detectable upon NLS addition
(Fig. S5B). Taken together, isoform E is characterized by a cytoplas-
mic localization and the FLAG-tagged protein is slightly stabilized
by addition of an SV40 NLS. This slight stabilization upon nuclear
localization indicates a possible degradation mechanism in the
cytoplasm.
3.3. Different MAX C-termini are able to stabilize or destabilize
heterologous proteins
To analyze if the E-speciﬁc aa have a general impact on protein
stability, we fused them to heterologous proteins. Further, speciﬁc
parts of the WT C-terminus were fused as control (Fig. 3). First, we
attached the C-terminal aa of isoform E (E99–134) and the aa of the
WT encoding the acidic region (WT135–148), the NLS (WT149–s. (A) Overview of GFP and luciferase constructs. Different regions of MAX WT and
aa of WT or isoform E (E), also see Fig. 2F for an overview of WT organization. (B)
ate the aa of the WT or isoform E (E) fused to the C-terminus of GFP/P. Anti-GFP was
shown after short and long exposure time (short/long exp.). (C) Quantiﬁcation of
m E (E) C-termini were fused to ﬁreﬂy luciferase and their inﬂuence on protein
trol. Numbers indicate the aa of WT or E fused to the C-terminus of ﬁreﬂy luciferase
the mouse ornithine decarboxylase gene (grey bar). n = 3–8, ⁄⁄P-value <0.01. (right)
fusions. Amounts are normalized to Renilla luciferase mRNA as transfection control.
C-terminal fusions. Western Blot (anti-GFP) of GFP/P-MAX constructs upon CHX
terminus of GFP/P. HeLa cells were treated with CHX for the indicated time points.
o b-Actin levels.
Fig. 4. Isoform E degradation mechanism and mutation of the destabilization domain. (A) Proteasome inhibitor treatment. HeLa cells transfected with FLAG-WT or -E were
treated with 10 lM of the proteasome inhibitor MG132 for 24 h. Proteins were analyzed using anti-FLAG antibody and anti-Actin as loading control. (B) Conservation of
isoform E speciﬁc aa. Homologous sequences from different species were analyzed using ClustalW2. Numbers indicate the amino acids of isoform E in humans. Grey boxes
indicate amino acids, which were mutated to alanine.  = fully conserved amino acid, : = conservation between groups of strongly similar properties, . = conservation between
groups of weakly similar properties. (C) Quantiﬁcation of isoform E-dependent destabilization by luciferase assays. The isoform E speciﬁc C-terminus as well as truncated and
mutated versions (compare Fig. 4B) were fused to ﬁreﬂy luciferase and the inﬂuence on protein expression was measured. Activity of Renilla luciferase was measured as
transfection control. Numbers indicate the amino acids of isoform E (E) fused to the C-terminus of ﬁreﬂy luciferase (luc2). n = 3–8, ⁄P-value <0.05, ⁄⁄P-value <0.01.
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Fig. 3A and B). In contrast to the WT situation, where the attach-
ment of the NLS results in higher protein expression (compare
Fig. 2F), attachment of the MAX NLS to GFP/P does not increase
protein expression. Attachment of the acidic region however did,
both, with or without the NLS sequence. This region contains sev-
eral CKII phosphorylation sites, which seem to be constitutively
phosphorylated in vivo [19]. Mutation of these sites reduces MYC
transforming activity even more than the WT protein [20]. Fusion
of the E-speciﬁc C-terminal aa to GFP/P considerably decreases
protein expression, arguing that these aa contain a protein destabi-
lization domain. To quantify these effects, the domains were also
fused to a luciferase reporter gene and protein activity was mea-
sured. Attachment of E99–134 reduced the expression level of ﬁre-
ﬂy luciferase 33-fold. This is a greater decrease as obtained with a
widely used destabilization domain from the mouse ornithine
decarboxylase gene, which reduces luciferase expression only 7-
fold (luc2/P, Fig. 3C) [21]. The WT domains have the same impact
on luciferase as on GFP/P expression, with the acidic region
increasing expression. To ensure, that the differences on protein
activity are due to a change in protein stability and do not arise
from different mRNA levels, we quantiﬁed the mRNA levels for dif-
ferent constructs with increased or decreased expression (Fig. 3C).
The mRNA levels of all constructs are equal, which solidiﬁes that
the E speciﬁc aa inﬂuence protein stability. To quantify the impact
of the different MAX domains on protein stability, we estimated
the protein half-life of GFP/P, GFP/P-E99–134 and GFP/P-WT135–
148 (Fig. 3D) by CHX treatment in HeLa cells. While GFP/P, without
any MAX aa, has a half-life of 11 h, the fusion protein containing
aa E99–134 is degraded much more rapidly (half-life of 3 h). For
the stabilizing aa WT135–148 no change in protein expression
is detectable after 24 h of CHX treatment. Taken together, the iso-
form E speciﬁc C-terminus contains a highly efﬁcient proteindestabilization domain, whereas WT aa 135–148 are able to stabi-
lize heterologous proteins.
We tested whether FLAG-E is degraded via the proteasome
pathway using the proteasome inhibitor MG132 (Fig. 4A). As we
could not detect any protein for isoform E after proteasome inhibi-
tion, we also tested chloroquine as inhibitor of lysosomal degrada-
tion plus eleven different protease inhibitors, to unravel the
degradation mechanism by which isoform E is destabilized
(Fig. S6). However, we could not detect any protein for isoform E.
Despite that, we started to analyze which aa within the E-speciﬁc
C-terminus are important for protein destabilization. For that, a
CLUSTALW2 alignment of the E-speciﬁc region with homologous
sequences from other species was done [22]. The ﬁrst 19 aa are
best conserved, so that we shortened the luciferase construct to
E99–117 and disrupted four conserved aa by substituting them
with alanine (Fig. 4B). Both constructs increased the luciferase
activity and an additive effect upon combination of mutation and
truncation can be observed. However, luciferase does not achieve
the original level of activity (Fig. 4C). Conservation of the 19 aa,
which are sufﬁcient to reduce luciferase expression, suggests that
isoform E encodes a highly unstable protein in other species as
well.
Taken together, we could show thatMAX is alternatively spliced
during hypoxia in HUVECs. Increased mRNA variants are unpro-
ductive in terms of protein expression and might solely serve to
downregulate WT expression. Alternative splicing coupled to
NMD, like shown here for isoform C, has been reported earlier as
regulation mechanism, which is often found in RNA binding pro-
teins [23,24]. In contrast to isoform C, isoform E is not targeted
by NMD, but encodes a highly unstable protein, which is not
detectable even after forced overexpression in HUVECs and HeLa
cells. However, we cannot exclude expression of isoform E under
different stress conditions or in different cell types, where it might
4790 K. Kemmerer, J.E. Weigand / FEBS Letters 588 (2014) 4784–4790serve a speciﬁc function, like it was shown for isoform C in
glioblastoma cells [16].
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